Fentanyl Cit 100mcg/2ml Pf Inj, 2ml
Overview
What is this medicine?
How to Use This Medicine
For proper storage and disposal of this medication, consult with your doctor, nurse, or pharmacist to determine the best approach, especially if you need to store it at home.
If you miss a dose, contact your doctor promptly to receive guidance on the next steps to take.
Lifestyle & Tips
- Avoid alcohol and other sedatives (e.g., benzodiazepines, sleeping pills) while receiving fentanyl, as this can lead to dangerous breathing problems and extreme drowsiness.
- Do not drive or operate heavy machinery immediately after receiving fentanyl, as it can impair your ability to do so safely.
- Report any difficulty breathing, extreme drowsiness, dizziness, or confusion to your healthcare provider immediately.
Available Forms & Alternatives
Available Strengths:
- Fentanyl 25mcg/hr Patch
- Fentanyl 50mcg/hr Patch
- Fentanyl 75mcg/hr Patch
- Fentanyl 100mcg/hr Patch
- Fentanyl Cit 0.05mg/ml Inj, 20ml
- Fentanyl Cit 0.05mg/ml Inj, 2ml
- Fentanyl Cit 0.05mg/ml Inj, 50ml
- Fentanyl Cit 0.05mg/ml Inj, 5ml
- Fentanyl Cit 800mcg Oral Transmcsl
- Fentanyl Cit 1200mcg Oral Transmcsl
- Fentanyl Cit 600mcg Oral Transmcsl
- Fentanyl Cit 1600mcg Oral Transmcsl
- Fentanyl Cit 400mcg Oral Transmcsl
- Fentanyl Cit 200mcg Oral Transmcsl
- Fentanyl 62.5mcg/hr Patch
- Fentanyl 87.5mcg/hr Patch
- Fentanyl Cit 600mcg Oraltransmcsl
- Fentanyl Cit 800mcg Oral Transmcsl
- Fentanyl Cit 1600mcg Oral Transmcsl
- Fentanyl Cit 100mcg Tablets
- Fentanyl Cit 200mcg Tablets
- Fentanyl 37.5mcg/hr Patch
- Fentanyl 62.5mcg/hr Patch
- Fentanyl Cit 50mcg/ml Pf Inj, 1ml
- Fentanyl 12mcg/hr Patch
- Fentanyl Cit 50mcg/1ml Inj, 10ml
- Fentanyl Cit 100mcg/2ml Pf Inj, 2ml
- Fentanyl Cit 25mcg/0.5ml Pf Inj
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
BLACK BOX WARNING
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of low blood sugar, including:
+ Dizziness
+ Headache
+ Feeling sleepy
+ Feeling weak
+ Shaking
+ Fast heartbeat
+ Confusion
+ Hunger
+ Sweating
Severe dizziness or passing out
Feeling confused
Severe constipation or stomach pain, which may indicate a severe bowel problem
Breathing difficulties, such as:
+ Trouble breathing
+ Slow breathing
+ Shallow breathing
+ Noisy breathing
+ Breathing problems during sleep (sleep apnea)
Chest pain
Abnormal heartbeat (fast or slow)
Seizures
Depression
Trouble controlling body movements
Swelling in the arms or legs
Changes in eyesight
Serotonin Syndrome: A Potentially Life-Threatening Condition
If you take this medication with certain other drugs, you may be at risk of developing serotonin syndrome, a severe and potentially deadly condition. Seek medical help immediately if you experience:
Agitation
Changes in balance
Confusion
Hallucinations
Fever
Abnormal heartbeat (fast or slow)
Flushing
Muscle twitching or stiffness
Seizures
Shivering or shaking
Excessive sweating
Severe diarrhea
Upset stomach
Vomiting
Severe headache
Adrenal Gland Problem: A Rare but Serious Condition
Taking an opioid medication like this one may lead to a rare but severe adrenal gland problem. Contact your doctor immediately if you experience:
Extreme fatigue or weakness
Passing out
Severe dizziness
Upset stomach
Vomiting
Decreased appetite
Other Possible Side Effects
While many people may not experience any side effects or only minor ones, it's essential to be aware of the following possible side effects:
Feeling dizzy, sleepy, tired, or weak
Dry mouth
Constipation
Diarrhea
Stomach pain
Upset stomach
Vomiting
Decreased appetite
Headache
Feeling cold
Trouble sleeping
Excessive sweating
* Irritation at the site of administration
If you experience any of these side effects or any other symptoms that concern you, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Slow, shallow, or difficult breathing
- Extreme drowsiness or inability to wake up
- Dizziness or lightheadedness when standing up
- Confusion or disorientation
- Bluish lips or fingernails
- Severe constipation or inability to urinate
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Respiratory problems like asthma, breathing difficulties, or sleep apnea
+ Elevated carbon dioxide levels in the blood
+ Stomach or bowel obstruction or narrowing
Kidney or liver disease
Recent use (within the last 14 days) of specific medications for depression or Parkinson's disease, such as isocarboxazid, phenelzine, tranylcypromine, selegiline, or rasagiline, as this may lead to severely high blood pressure
* Current use of certain medications, including buprenorphine, butorphanol, linezolid, methylene blue, nalbuphine, or pentazocine
This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Do not initiate, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
Inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Caution with Daily Activities
Avoid driving and performing tasks that require alertness until you understand how this medication affects you. To minimize the risk of dizziness or fainting, rise slowly from a sitting or lying position. Be cautious when climbing stairs.
Tolerance and Dependence
Long-term or high-dose use of this medication may lead to tolerance, where the medication becomes less effective, and higher doses may be required to achieve the same effect. If you experience a decrease in the medication's effectiveness, consult your doctor. Do not take more than the prescribed dose.
Additionally, long-term or regular use of opioid medications like this one may cause dependence. Suddenly stopping or reducing the dose may increase the risk of withdrawal or severe problems. Consult your doctor before changing your dose or stopping the medication, and follow their instructions carefully. Monitor for signs of withdrawal, increased pain, mood changes, suicidal thoughts, or other adverse effects, and report them to your doctor.
Safe Use
Do not exceed the prescribed dose, frequency, or duration of treatment, as this may increase the risk of severe side effects. Avoid taking this medication with other strong pain medications or using a pain patch without consulting your doctor first.
If your pain worsens, you become more sensitive to pain, or you experience new pain, contact your doctor immediately. Do not take more than the prescribed dose.
Interactions and Contraindications
If you consume grapefruit juice or eat grapefruit regularly, discuss this with your doctor. Do not take this medication with alcohol or products containing alcohol, as this may cause unsafe and potentially fatal effects.
Seizure Risk
This medication may increase the risk of seizures in some individuals, including those with a history of seizures. Consult your doctor to determine if you are at higher risk.
Hormonal Effects
Long-term use of opioid medications may lead to decreased sex hormone levels. If you experience a decrease in libido, fertility problems, irregular menstrual periods, or ejaculation problems, contact your doctor.
Special Populations
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
Breastfeeding
If you are breastfeeding, inform your doctor, as this medication passes into breast milk and may harm your baby. Seek medical attention immediately if your baby appears overly sleepy, limp, or has breathing difficulties.
Overdose Information
Overdose Symptoms:
- Severe respiratory depression (slowed or stopped breathing)
- Extreme somnolence progressing to stupor or coma
- Pinpoint pupils (miosis)
- Flaccid skeletal muscle
- Cold, clammy skin
- Bradycardia
- Hypotension
- Circulatory collapse
- Death
What to Do:
Seek immediate emergency medical attention. Call 911 or your local emergency number. Administer naloxone if available and trained to do so. Provide ventilatory support as needed. Call 1-800-222-1222 (Poison Control).
Drug Interactions
Contraindicated Interactions
- Monoamine Oxidase Inhibitors (MAOIs) concurrently or within 14 days of MAOI therapy (risk of serotonin syndrome or severe, unpredictable reactions)
Major Interactions
- Other CNS depressants (e.g., benzodiazepines, other opioids, alcohol, sedatives, hypnotics, general anesthetics, phenothiazines, tranquilizers, skeletal muscle relaxants): Increased risk of profound sedation, respiratory depression, coma, and death.
- CYP3A4 inhibitors (e.g., ritonavir, ketoconazole, itraconazole, clarithromycin, erythromycin, diltiazem, verapamil, grapefruit juice): Increased fentanyl plasma concentrations, leading to increased and prolonged opioid effects, including respiratory depression.
- Serotonergic drugs (e.g., SSRIs, SNRIs, TCAs, triptans, mirtazapine, tramadol): Risk of serotonin syndrome.
Moderate Interactions
- CYP3A4 inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): Decreased fentanyl plasma concentrations, potentially leading to reduced efficacy or withdrawal symptoms.
- Anticholinergic drugs: Increased risk of urinary retention and/or severe constipation.
Minor Interactions
- Not specifically categorized as minor for fentanyl due to its potency and narrow therapeutic index; all interactions should be considered significant.
Monitoring
Baseline Monitoring
Rationale: To establish baseline pain level and guide initial dosing.
Timing: Prior to administration
Rationale: To assess baseline respiratory function, as respiratory depression is a primary adverse effect.
Timing: Prior to administration
Rationale: To assess baseline oxygenation.
Timing: Prior to administration
Rationale: To establish baseline mental status and assess risk of over-sedation.
Timing: Prior to administration
Rationale: To assess baseline cardiovascular status, as fentanyl can cause bradycardia and hypotension.
Timing: Prior to administration
Routine Monitoring
Frequency: Every 5-15 minutes initially, then every 1-4 hours or as clinically indicated, especially after dose changes.
Target: Adults: 12-20 breaths/min (adjust for age/condition)
Action Threshold: <10 breaths/min (adults), shallow breathing, or signs of respiratory distress; administer naloxone, provide ventilatory support.
Frequency: Continuous or every 5-15 minutes initially, then every 1-4 hours or as clinically indicated.
Target: >92-94% (or patient's baseline)
Action Threshold: <90% or significant drop from baseline; administer supplemental oxygen, consider naloxone.
Frequency: Every 5-15 minutes initially, then every 1-4 hours or as clinically indicated.
Target: Alert to mildly drowsy (S1-S2)
Action Threshold: Difficult to arouse (S3) or unarousable (S4); hold dose, stimulate patient, consider naloxone.
Frequency: Every 1-4 hours or as clinically indicated.
Target: Patient-specific goal (e.g., <4/10 on a 0-10 scale)
Action Threshold: Uncontrolled pain; consider additional dose, alternative analgesia, or non-pharmacologic interventions.
Frequency: Every 5-15 minutes initially, then every 1-4 hours or as clinically indicated.
Target: Within patient's normal range
Action Threshold: Significant hypotension or bradycardia; consider fluid bolus, vasopressors, or atropine.
Symptom Monitoring
- Respiratory depression (slow, shallow breathing, cyanosis)
- Excessive sedation/drowsiness
- Nausea and vomiting
- Constipation
- Pruritus
- Urinary retention
- Dizziness
- Confusion
- Muscle rigidity (especially with rapid IV administration or high doses)
Special Patient Groups
Pregnancy
Use during pregnancy should be avoided unless the potential benefits outweigh the potential risks. Prolonged use during pregnancy can lead to neonatal opioid withdrawal syndrome (NOWS) in the newborn, which can be life-threatening if not recognized and treated.
Trimester-Specific Risks:
Lactation
Fentanyl is excreted into breast milk. A single dose is generally considered compatible with breastfeeding if the infant is monitored for sedation and respiratory depression. For repeated doses or continuous infusions, caution is advised, and an alternative analgesic may be preferred. Monitor the infant for increased sleepiness, difficulty breathing, or poor feeding.
Pediatric Use
Pediatric patients, especially infants and neonates, are more sensitive to the respiratory depressant effects of opioids. Dosing must be highly individualized and carefully titrated based on age, weight, clinical condition, and concomitant medications. Close monitoring for respiratory depression and sedation is crucial.
Geriatric Use
Elderly patients may be more sensitive to the effects of fentanyl, including respiratory depression, sedation, and constipation. Start with lower doses and titrate slowly. Monitor closely for adverse effects. Reduced hepatic and renal function in the elderly may prolong fentanyl's effects.
Clinical Information
Clinical Pearls
- Fentanyl is highly potent; even small errors in dosing can lead to severe respiratory depression or death.
- Rapid IV administration can cause chest wall rigidity, making ventilation difficult. Administer slowly over 1-2 minutes.
- Tolerance and physical dependence can develop with prolonged use, even at therapeutic doses.
- Always have naloxone readily available when administering fentanyl.
- Monitor patients closely for at least 2 hours after the last dose due to potential for delayed or recurrent respiratory depression.
- Concomitant use with benzodiazepines or other CNS depressants significantly increases the risk of serious adverse events, including death. Reserve concomitant prescribing for patients for whom alternative treatment options are inadequate.
Alternative Therapies
- Other opioid analgesics (e.g., morphine, hydromorphone, oxycodone, sufentanil, remifentanil)
- Non-opioid analgesics (e.g., NSAIDs, acetaminophen) for mild to moderate pain
- Regional anesthesia/analgesia (e.g., nerve blocks, epidural analgesia)
- Non-pharmacologic pain management strategies (e.g., physical therapy, heat/cold therapy, massage, acupuncture)
Cost & Coverage
General Drug Facts
To dispose of unused doses, follow the instructions provided with your medication. If you have questions or concerns about disposal, consult your pharmacist. Additionally, some medications may come with a separate patient information leaflet; check with your pharmacist for more information. If you have any questions or concerns about your medication, discuss them with your doctor, nurse, pharmacist, or other healthcare provider.
In the event of an overdose, a medication called naloxone can be used as part of the treatment. Consult your doctor or pharmacist about obtaining or using naloxone. If you suspect an overdose, seek immediate medical attention, even if naloxone has been administered. Be prepared to provide information about the overdose, including the substance taken, the amount, and the time it occurred. You can also contact your local poison control center or seek emergency medical care, providing the same detailed information about the overdose.